Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khramtsova

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Springerplus|July 8, 2016
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancerRita Nanda, Erica M Stringer-Reasor, Poornima Saha, et al.
Nature Communications|February 7, 2013
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancerLi-Jun Di, Jung S Byun, Madeline M Wong, et al.
Breast Cancer Research : BCR|May 25, 2023
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populationsMinoru Miyashita, Joshua S K Bell, Stephane Wenric, et al.
International Journal of Cancer|June 8, 2019
Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and NigeriaShengfeng Wang, Jason J Pitt, Yonglan Zheng, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 8, 2020
The Evolutionary History of Common Genetic Variants Influencing Human Cortical Surface AreaAmanda K Tilot, Ekaterina A Khramtsova, Dan Liang, et al.
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
Cancer Letters|January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <i>BRCA1</i> Mutation CarriersRodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Springerplus|July 8, 2016
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancerRita Nanda, Erica M Stringer-Reasor, Poornima Saha, et al.
Nature Communications|February 7, 2013
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancerLi-Jun Di, Jung S Byun, Madeline M Wong, et al.
Breast Cancer Research : BCR|May 25, 2023
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populationsMinoru Miyashita, Joshua S K Bell, Stephane Wenric, et al.
International Journal of Cancer|June 8, 2019
Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and NigeriaShengfeng Wang, Jason J Pitt, Yonglan Zheng, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 8, 2020
The Evolutionary History of Common Genetic Variants Influencing Human Cortical Surface AreaAmanda K Tilot, Ekaterina A Khramtsova, Dan Liang, et al.
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
Cancer Letters|January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <i>BRCA1</i> Mutation CarriersRodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, et al.
Pageof 14